MELASYL EFFICACY UNDER PART OF VISIBLE LIGHT (NCT06937515) | Clinical Trial Compass
CompletedNot Applicable
MELASYL EFFICACY UNDER PART OF VISIBLE LIGHT
Romania31 participantsStarted 2023-03-27
Plain-language summary
The study intends to evaluate the efficacy of an anti-melanogenesis active in different concentrations under part of visible Light \[400-450nm\] exposures and under full visible light \[400-700nm\] exposures.
It is carried out on cosmetic products for which the safety has been assured by a toxicologist, with the aim of confirming the efficacy of the products, which will be used by a large number of consumers under normal and reasonably foreseeable use conditions.
Who can participate
Age range18 Years β 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
β. Healthy female or male volunteer from 18 to 65 years old
β. Skin type III-IV according to the Fitzpatrick classification
β. Average ITAΒ° (Individual Typologic Angle calculated value) on the back between 18Β° and 34Β° at screening and inclusion visits with an allowed difference of Β± 2Β° between screening and inclusion visits
β. Uniform skin color over the eight zones (difference in ITAΒ° between each zone should not be more than 4Β°)
β. Absence of freckles, naevi, hypo or hyper pigmented regions, hairs and marks of bronzing on the investigational area on the back
β. Female subject of childbearing potential, who is not sexually active, or using an effective contraceptive method\* for at least one month before the beginning of the study, and throughout the study or menopausal female (with absence of menstruations for less than one year) or post-menopausal female (with absence of menstruations for more than one year)
β. Female of childbearing potential or menopausal female (with absence of menstruations for less than one year) willing to undergo urine pregnancy test
β. Subject willing and able to fulfil the study requirements and schedule
Exclusion criteria
β. Subject who is pregnant or lactating or who is planning to become pregnant during the study
. Having planned UV exposure of the investigational area (sunlight or sunbeds) throughout the study
β. Having used sunbeds or had excessive sun exposure of the investigational area within the 3 months before inclusion
β. Having sunburn (erythema) on the back
β. Dermatological disorders affecting the investigational area (presence of naevi, freckles, excess hair or uneven skin tones, vitiligo, photo-dermatological problems